BIRC5 and urinary bladder carcinoma: demonstrated that silencing survivin enhanced activity of MMC in human bladder RT4 xenografts, representing a potentially useful chemo-gene therapy for bladder cancer (96). These data indicate that combination of MMC can be a useful approach to improve the effect of chemotherapy.